Palisade Bio logo

Palisade Bio Share Price Today

(NASDAQ: PALI)

Palisade Bio share price is $0.82 & ₹71.31 as on 6 Mar 2025, 2.30 'hrs' IST

$0.82

0.02

(3.09%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Palisade Bio share price in Dollar and Rupees. Guide to invest in Palisade Bio stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Palisade Bio, along with analyst recommendations, forecasts, and comprehensive financials.

Palisade Bio share price movements

  • Today's Low: $0.80
    Today's High: $0.85

    Day's Volatility :5.77%

  • 52 Weeks Low: $0.78
    52 Weeks High: $9.65

    52 Weeks Volatility :91.87%

Palisade Bio (PALI) Returns

PeriodPalisade Bio IncIndex (Russel 2000)
3 Months
-54.35%
0.0%
6 Months
-78.23%
0.0%
1 Year
-87.21%
0.0%
3 Years
-98.12%
-11.6%

Palisade Bio (PALI) Key Statistics

in dollars & INR

Previous Close
$0.7988
Open
$0.8
Today's High
$0.849
Today's Low
$0.8
Market Capitalization
$2.5M
Today's Volume
$3.5K
52 Week High
$9.65
52 Week Low
$0.7848
Revenue TTM
$0.0
EBITDA
$-14.4M
Earnings Per Share (EPS)
$-13.44
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-135.96%

How to invest in Palisade Bio Stock (PALI) from India?

It is very easy for Indian residents to invest directly in Palisade Bio from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Palisade Bio stock in both Indian Rupees (INR) and US Dollars (USD). Search for Palisade Bio or PALI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Palisade Bio or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Palisade Bio shares which would translate to 1.061 fractional shares of Palisade Bio as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Palisade Bio, in just a few clicks!

Returns in Palisade Bio (PALI) for Indian investors in Rupees

The Palisade Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Palisade Bio investment value today

Current value as on today

₹18,083

Returns

₹81,917

(-81.92%)

Returns from Palisade Bio Stock

₹86,880 (-86.88%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Palisade Bio (PALI)

-18%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Palisade Bio Stock from India on INDmoney has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Palisade Bio

  • Armistice Capital, LLC

    3.55%

  • Cetera Investment Advisers

    2.36%

  • Geode Capital Management, LLC

    0.34%

  • UBS Group AG

    0.30%

  • Tower Research Capital LLC

    0.16%

Analyst Recommendation on Palisade Bio

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Palisade Bio(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Palisade Bio Stock (PALI)

What analysts predicted

Upside of 2339.02%

Target:

$20.00

Current:

$0.82

Insights on Palisade Bio Stock (Ticker Symbol: PALI)

  • Price Movement

    In the last 1 month, PALI stock has moved down by -39.9%
  • PALI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 149.2%
  • PALI vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 146.0%

Palisade Bio Technicals Summary

Sell

Neutral

Buy

Palisade Bio is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Palisade Bio (PALI) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Palisade Bio Inc logo
-40.83%
-78.23%
-87.21%
-98.12%
-99.84%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Palisade Bio Inc logo
0.02
NA
NA
-11.66
-1.36
-0.68
NA
5.51
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Palisade Bio Inc logo
Buy
$2.5M
-99.84%
0.02
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Palisade Bio

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor, currently under pre-clinical development as a therapeutic for patients living with inflammatory bowel diseases, including ulcerative colitis and Crohn's disease (CD), as well as develops PALI-1908, an oral, selective PDE4 inhibitor prodrug that is locally bioactivated in the terminal ileum of CD patients, currently in the research stage. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California; a co-development and distribution agreement with Newsoara Biopharma Co., Ltd; and a transformative strategic collaboration with Strand Life Sciences for advancing precision medicine for ulcerative colitis therapy. The company is based in Carlsbad, California.
Organization
Palisade Bio
Employees
9
CEO
Mr. J. D. Finley
Industry
Miscellaneous

Management People of Palisade Bio

NameTitle
Mr. J. D. Finley
CEO, CFO & Director
Dr. Mitchell Lawrence Jones M.D., Ph.D.
COO & Chief Medical Officer
Dr. Joerg Heyer Ph.D.
Head of Translational Science & Medicine
Mr. Ryker Willie
Senior VP of Finance & Corporate Controller

Important FAQs about investing in PALI Stock from India :

What is Palisade Bio share price today?

Palisade Bio share price today stands at $0.82, Open: $0.80 ; Previous Close: $0.80 ; High: $0.85 ; Low: $0.80 ; 52 Week High: $9.65 ; 52 Week Low: $0.78.

The stock opens at $0.80, after a previous close of $0.80. The stock reached a daily high of $0.85 and a low of $0.80, with a 52-week high of $9.65 and a 52-week low of $0.78.

Can Indians buy Palisade Bio shares?

Yes, Indians can invest in the Palisade Bio (PALI) from India.

With INDmoney, you can buy Palisade Bio at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Palisade Bio at zero transaction cost.

How can I buy Palisade Bio shares from India?

It is very easy to buy Palisade Bio from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Palisade Bio (PALI) be purchased?

Yes, you can buy fractional shares of Palisade Bio with INDmoney app.

What are the documents required to start investing in Palisade Bio stocks?

To start investing in Palisade Bio, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Palisade Bio Stock (PALI)?

Today’s highest price of Palisade Bio (PALI) is $0.85.

Today’s lowest price of Palisade Bio (PALI) is $0.80.

What is today's market capitalisation of Palisade Bio?

Today's market capitalisation of Palisade Bio PALI is 2.5M

What is the 52 Week High and Low Range of Palisade Bio Stock (PALI)?

  • 52 Week High

    $9.65

  • 52 Week Low

    $0.78

What are the historical returns of Palisade Bio (PALI)?

  • 1 Month Returns

    -40.83%

  • 3 Months Returns

    -78.23%

  • 1 Year Returns

    -87.21%

  • 5 Years Returns

    -99.84%

Who is the Chief Executive Officer (CEO) of Palisade Bio ?

Mr. J. D. Finley is the current Chief Executive Officer (CEO) of Palisade Bio.